By Lauren Berg ( August 18, 2021, 9:50 PM EDT) -- Illumina Inc. announced Wednesday that it completed its planned $7.1 billion acquisition of Grail, a biotechnology company focused on early-detection cancer testing using DNA, even as the deal faces a legal challenge from the Federal Trade Commission and antitrust scrutiny in Europe....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.